What Are Stem Cells?
AURELIA / STEM CELLS

What Are Stem Cells

Understand the cells, the different technologies and the route from laboratory to clinical care.

SEE / UNDERSTAND / ASK

Understand the science visually

Open any image at full size. Research pictures, original schematics and generated concepts are labelled separately; none is an Aurelia patient outcome.

Self-renewal and differentiation — Simplified teaching schematic; cell identity and requirements depend on the actual cell type and intended use.
Principle schematic

Self-renewal and differentiation

Simplified teaching schematic; cell identity and requirements depend on the actual cell type and intended use.

Original schematic · Aurelia · Scientific reference ↗
From hESCs to neurons — Panel A shows human embryonic stem cells; B shows derived neurons. These are hESCs, not iPSCs or patient before/after photographs.
Published research image

From hESCs to neurons

Panel A shows human embryonic stem cells; B shows derived neurons. These are hESCs, not iPSCs or patient before/after photographs.

Images: Nissim Benvenisty · CC BY 2.5
Image source ↗ · Original research / source ↗
Format and display notes

保留完整画幅和原有标注,仅等比例缩小并转WebP;原始文件同时保留。

H9 human embryonic stem-cell colony — The central H9/WA09 colony is human; surrounding feeder cells are mouse fibroblasts. The source describes 10× microscopy.
Published research image

H9 human embryonic stem-cell colony

The central H9/WA09 colony is human; surrounding feeder cells are mouse fibroblasts. The source describes 10× microscopy.

Ryddragyn at English Wikipedia · Public domain
Image source ↗ · Original research / source ↗
Format and display notes

保留完整画幅和原有标注,仅等比例缩小并转WebP;原始文件同时保留。

Human umbilical-cord MSCs — Primary-culture morphology from different human umbilical-cord regions. A laboratory comparison, not clinical efficacy data.
Published research image

Human umbilical-cord MSCs

Primary-culture morphology from different human umbilical-cord regions. A laboratory comparison, not clinical efficacy data.

Subramanian A, Fong C-Y, Biswas A, Bongso A · CC BY 4.0
Image source ↗ · Original research / source ↗
Format and display notes

保留完整画幅和原有标注,仅等比例缩小并转WebP;原始文件同时保留。

Two defining abilities

Stem cells can renew their own population and generate specialised cells. Their potential depends on cell type and culture conditions; being a stem cell does not itself establish clinical benefit.

Adult and tissue-specific cells

Blood-forming stem cells replenish blood and immune cells. Other tissue stem cells have different roles. Haematopoietic transplantation for selected conditions is distinct from an undefined wellness infusion.

MSC is not iPSC

Mesenchymal stromal cells and pluripotent cells are different platforms. iPSCs are reprogrammed cells with broad differentiation potential. Clinical products generally require defined manufacture and a target cell identity; they are not interchangeable.

Autologous and donor cells

Autologous cells originate from the recipient; allogeneic cells come from a donor. Autologous origin does not universally eliminate autoimmunity, manufacturing risk or the need for immunosuppression.

From research to a product

A research result needs reproducibility, a defined product, quality controls, nonclinical safety, clinical evidence and the applicable regulatory route. Trial registration, a patent and a licence agreement each serve different purposes.

Questions worth asking

Ask which cells and indication, which authorisation, what clinical evidence, what administration, what risks and what follow-up. Obtain an explanation of alternatives and who is clinically accountable.